Cumberland Pharmaceuticals Inc. (CPIX): Price and Financial Metrics

Cumberland Pharmaceuticals Inc. (CPIX): $3.08

-0.01 (-0.32%)

POWR Rating

Component Grades













CPIX Stock Summary

  • CPIX has a market capitalization of $44,171,823 -- more than approximately merely 7.8% of US stocks.
  • In terms of volatility of its share price, CPIX is more volatile than merely 5.99% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CPIX comes in at 11.82% -- higher than that of 83.02% of stocks in our set.
  • Stocks that are quantitatively similar to CPIX, based on their financial statements, market capitalization, and price volatility, are PRDO, OESX, MOV, SMP, and FSI.
  • Visit CPIX's SEC page to see the company's official filings. To visit the company's web site, go to

CPIX Price Target

For more insight on analysts targets of CPIX, see our CPIX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $8.50 Average Broker Recommendation 1.75 (Moderate Buy)

CPIX Stock Price Chart Interactive Chart >

Price chart for CPIX

CPIX Price/Volume Stats

Current price $3.08 52-week high $3.94
Prev. close $3.09 52-week low $2.58
Day low $3.03 Volume 23,800
Day high $3.10 Avg. volume 51,460
50-day MA $2.92 Dividend yield N/A
200-day MA $3.10 Market Cap 46.35M

Cumberland Pharmaceuticals Inc. (CPIX) Company Bio

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the hospital acute care and gastroenterology markets in the United States and internationally. The company was founded in 1999 and is based in Nashville, Tennessee.

CPIX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$3.08$1.59 -47%

We started the process of determining a valid price forecast for Cumberland Pharmaceuticals Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cumberland Pharmaceuticals Inc ranked in the 38th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Cumberland Pharmaceuticals Inc, consider:

  • The compound growth rate in the free cash flow of Cumberland Pharmaceuticals Inc over the past 5.77 years is 0.04%; that's better than only 23.92% of cash flow producing equities in the Healthcare sector, where it is classified.
  • Cumberland Pharmaceuticals Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -7.19. This coverage rate is greater than that of only 8.79% of stocks we're observing for the purpose of forecasting via discounted cash flows.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

CAH, EHC, A, AMGN, and BSX can be thought of as valuation peers to CPIX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

CPIX Latest News Stream

Event/Time News Detail
Loading, please wait...

CPIX Latest Social Stream

Loading social stream, please wait...

View Full CPIX Social Stream

Latest CPIX News From Around the Web

Below are the latest news stories about Cumberland Pharmaceuticals Inc that investors may wish to consider to help them evaluate CPIX as an investment opportunity.

Is Cumberland (CPIX) a Solid Growth Stock? 3 Reasons to Think " Yes "

Cumberland (CPIX) could produce exceptional returns because of its solid growth attributes.

Yahoo | June 2, 2021

Cumberland Pharmaceuticals names John Hamm as chief financial officer

Cumberland Pharmaceuticals ([[CPIX]] +2.3%) announces the promotion of John Hamm as the company's Director Finance & Accounting and Chief Financial Officer.In this role, he will manage all of Cumberland's finance and accounting activities while continuing to oversee corporate development and legal matters.Hamm has more than 25 years of finance and accounting experience, including 20...

Seeking Alpha | May 19, 2021

Cumberland Pharma Promotes John Hamm As CFO

(RTTNews) - Specialty pharmaceutical company Cumberland Pharmaceuticals Inc. (CPIX) announced on Wednesday that it has promoted John Hamm to Director, Finance & Accounting and Chief Financial Officer. In his new role as CFO, Hamm will oversee all of the company''s finance and accounting activities even while overseeing corporate development and

Business Insider Markets | May 19, 2021

Cumberland: Q1 Earnings Snapshot

NASHVILLE, Tenn. (AP) _ Cumberland Pharmaceuticals Inc. (CPIX) on Tuesday reported first-quarter net income of $167,000, after reporting a loss in the same period a year earlier. On a per-share basis, the Nashville, Tennessee-based company said it had profit of 1 cent. Earnings, adjusted for one-time gains and costs, came to 7 cents per share. []

CityNews Vancouver | May 11, 2021

Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update

NASHVILLE, Tenn., May 11, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial results. Net revenues from continuing operations during the quarter were $10.5 million, a

PR Newswire | May 11, 2021

Read More 'CPIX' Stories Here

CPIX Price Returns

1-mo 11.19%
3-mo -4.35%
6-mo -1.91%
1-year -7.78%
3-year -48.75%
5-year -31.56%
YTD 4.41%
2020 -42.72%
2019 -14.59%
2018 -18.07%
2017 33.82%
2016 4.56%

Continue Researching CPIX

Here are a few links from around the web to help you further your research on Cumberland Pharmaceuticals Inc's stock as an investment opportunity:

Cumberland Pharmaceuticals Inc (CPIX) Stock Price | Nasdaq
Cumberland Pharmaceuticals Inc (CPIX) Stock Quote, History and News - Yahoo Finance
Cumberland Pharmaceuticals Inc (CPIX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7852 seconds.